Novel organic arsenic molecule darinaparsin: Development of IV and oral forms
Izidore S. Lossos(University of Miami), Wilson H. Miller(Jewish General Hospital), Philip Komarnitsky(Rodin Therapeutics (United States)), Michael Craig(Edith Cowan University), Paul Conkling(Virginia Oncology Associates), Carlos Becerra(Texas Oncology), Betty L. Hamilton(Baylor University Medical Center), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Ralph V. Boccia(Center for Cancer and Blood Disorders), J. Lewis(Baylor University Medical Center)
Cited by 5
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k